| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperoxia | 39 | 2023 | 133 | 12.370 |
Why?
|
| Cytochrome P-450 CYP1A1 | 39 | 2023 | 102 | 7.620 |
Why?
|
| Lung Injury | 18 | 2023 | 131 | 6.320 |
Why?
|
| Cytochrome P-450 CYP1A2 | 19 | 2023 | 63 | 5.110 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 13 | 2023 | 70 | 4.770 |
Why?
|
| Acute Lung Injury | 11 | 2022 | 92 | 4.620 |
Why?
|
| Bronchopulmonary Dysplasia | 15 | 2023 | 161 | 4.610 |
Why?
|
| Receptors, Aryl Hydrocarbon | 22 | 2023 | 85 | 4.530 |
Why?
|
| DNA Adducts | 24 | 2019 | 210 | 3.210 |
Why?
|
| Lung | 32 | 2023 | 3151 | 3.120 |
Why?
|
| Methylcholanthrene | 11 | 2010 | 29 | 2.750 |
Why?
|
| Cytochrome P-450 Enzyme System | 14 | 2023 | 200 | 2.720 |
Why?
|
| Carcinogens | 11 | 2015 | 384 | 2.450 |
Why?
|
| Liver | 29 | 2023 | 2961 | 2.210 |
Why?
|
| Oxidative Stress | 13 | 2021 | 1129 | 2.170 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 7 | 2022 | 622 | 1.880 |
Why?
|
| Oxygen | 10 | 2023 | 754 | 1.590 |
Why?
|
| Cytochrome P-450 CYP1B1 | 8 | 2018 | 42 | 1.500 |
Why?
|
| Omeprazole | 5 | 2016 | 92 | 1.270 |
Why?
|
| Mice, Inbred C57BL | 28 | 2023 | 6942 | 1.250 |
Why?
|
| beta-Naphthoflavone | 6 | 2020 | 13 | 1.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2023 | 268 | 1.200 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 5 | 2021 | 60 | 1.170 |
Why?
|
| Animals | 86 | 2023 | 59536 | 1.070 |
Why?
|
| Gene Expression Regulation | 16 | 2022 | 4053 | 1.000 |
Why?
|
| Cytochrome P-450 CYP3A | 6 | 2019 | 83 | 0.990 |
Why?
|
| Pulmonary Alveoli | 7 | 2019 | 208 | 0.940 |
Why?
|
| Enzyme Induction | 15 | 2018 | 249 | 0.910 |
Why?
|
| Transcriptional Activation | 4 | 2011 | 1070 | 0.900 |
Why?
|
| Mice, Knockout | 18 | 2023 | 5710 | 0.890 |
Why?
|
| Gene Expression Regulation, Enzymologic | 8 | 2016 | 703 | 0.860 |
Why?
|
| Microsomes, Liver | 10 | 2012 | 115 | 0.850 |
Why?
|
| Transcriptome | 5 | 2019 | 1859 | 0.840 |
Why?
|
| Benzo(a)pyrene | 8 | 2014 | 35 | 0.830 |
Why?
|
| Neutrophil Infiltration | 7 | 2016 | 109 | 0.810 |
Why?
|
| Animals, Newborn | 14 | 2023 | 1338 | 0.790 |
Why?
|
| Mice | 51 | 2023 | 34495 | 0.790 |
Why?
|
| Environmental Pollution | 1 | 2019 | 19 | 0.690 |
Why?
|
| DNA Damage | 4 | 2018 | 1954 | 0.690 |
Why?
|
| Sex Characteristics | 4 | 2021 | 417 | 0.660 |
Why?
|
| Carcinogenesis | 2 | 2021 | 1026 | 0.630 |
Why?
|
| DNA | 14 | 2007 | 2693 | 0.610 |
Why?
|
| Promoter Regions, Genetic | 7 | 2018 | 3101 | 0.600 |
Why?
|
| Gene Expression Profiling | 6 | 2019 | 5159 | 0.570 |
Why?
|
| Enzyme Inhibitors | 6 | 2017 | 1879 | 0.550 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 6 | 2012 | 78 | 0.550 |
Why?
|
| Proton Pump Inhibitors | 2 | 2015 | 249 | 0.550 |
Why?
|
| Chromatography, Thin Layer | 2 | 2015 | 70 | 0.540 |
Why?
|
| Tretinoin | 2 | 2010 | 623 | 0.540 |
Why?
|
| Rifampin | 2 | 2018 | 191 | 0.540 |
Why?
|
| Infant, Newborn | 11 | 2023 | 8223 | 0.520 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2015 | 90 | 0.520 |
Why?
|
| Protective Agents | 1 | 2015 | 51 | 0.520 |
Why?
|
| Deoxyadenosines | 1 | 2015 | 42 | 0.520 |
Why?
|
| Placenta | 1 | 2019 | 516 | 0.510 |
Why?
|
| Docosahexaenoic Acids | 1 | 2015 | 79 | 0.510 |
Why?
|
| Rats | 23 | 2017 | 6086 | 0.490 |
Why?
|
| Premature Birth | 1 | 2019 | 407 | 0.490 |
Why?
|
| Respiratory Mucosa | 1 | 2015 | 206 | 0.480 |
Why?
|
| Infant, Premature | 4 | 2022 | 787 | 0.460 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2016 | 1538 | 0.450 |
Why?
|
| Blotting, Western | 9 | 2017 | 3536 | 0.450 |
Why?
|
| Proteome | 1 | 2017 | 561 | 0.450 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 1021 | 0.440 |
Why?
|
| Pentachlorophenol | 4 | 1996 | 4 | 0.440 |
Why?
|
| Metabolic Detoxication, Phase II | 2 | 2011 | 17 | 0.430 |
Why?
|
| Paclitaxel | 2 | 2017 | 1996 | 0.420 |
Why?
|
| Carcinogens, Environmental | 3 | 2010 | 26 | 0.410 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 7222 | 0.410 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 34 | 0.410 |
Why?
|
| Lipid Peroxidation | 4 | 2018 | 157 | 0.410 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2020 | 249 | 0.400 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2008 | 2063 | 0.400 |
Why?
|
| Fish Oils | 1 | 2011 | 88 | 0.400 |
Why?
|
| Organ Size | 5 | 2015 | 690 | 0.390 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2003 | 330 | 0.380 |
Why?
|
| Benzopyrenes | 2 | 2003 | 11 | 0.370 |
Why?
|
| Interleukin-6 | 1 | 2015 | 1038 | 0.370 |
Why?
|
| Pneumonia | 1 | 2016 | 751 | 0.360 |
Why?
|
| Pregnancy | 9 | 2023 | 7573 | 0.350 |
Why?
|
| Luciferases | 4 | 2016 | 445 | 0.340 |
Why?
|
| Genes, Reporter | 5 | 2016 | 798 | 0.340 |
Why?
|
| Humans | 46 | 2023 | 261506 | 0.340 |
Why?
|
| Female | 46 | 2023 | 141928 | 0.330 |
Why?
|
| Glutathione Transferase | 3 | 2008 | 359 | 0.330 |
Why?
|
| Tamoxifen | 4 | 1997 | 876 | 0.330 |
Why?
|
| Anticarcinogenic Agents | 1 | 2010 | 362 | 0.320 |
Why?
|
| RNA, Messenger | 11 | 2015 | 6150 | 0.320 |
Why?
|
| Glucuronosyltransferase | 4 | 2017 | 104 | 0.300 |
Why?
|
| Male | 36 | 2023 | 123000 | 0.300 |
Why?
|
| Transfection | 4 | 2016 | 2944 | 0.300 |
Why?
|
| DNA Repair | 5 | 2017 | 1872 | 0.290 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2021 | 119 | 0.280 |
Why?
|
| Endothelial Cells | 4 | 2015 | 1048 | 0.280 |
Why?
|
| Isoxazoles | 2 | 2017 | 81 | 0.270 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 11538 | 0.270 |
Why?
|
| Body Weight | 4 | 2015 | 1293 | 0.270 |
Why?
|
| Hep G2 Cells | 3 | 2018 | 155 | 0.270 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2016 | 2508 | 0.260 |
Why?
|
| Sulfotransferases | 2 | 1995 | 36 | 0.260 |
Why?
|
| Lipopolysaccharides | 4 | 2016 | 558 | 0.260 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2017 | 203 | 0.250 |
Why?
|
| Dinoprost | 2 | 2015 | 33 | 0.250 |
Why?
|
| Random Allocation | 3 | 2015 | 703 | 0.250 |
Why?
|
| Growth Differentiation Factor 15 | 3 | 2023 | 24 | 0.240 |
Why?
|
| Cytochrome P-450 Enzyme Inhibitors | 2 | 2002 | 10 | 0.240 |
Why?
|
| Cell Proliferation | 2 | 2016 | 7226 | 0.240 |
Why?
|
| Bentonite | 1 | 2023 | 1 | 0.240 |
Why?
|
| Cells, Cultured | 9 | 2017 | 5637 | 0.240 |
Why?
|
| Injections, Intraperitoneal | 3 | 2015 | 197 | 0.240 |
Why?
|
| Blood Vessels | 1 | 2005 | 217 | 0.230 |
Why?
|
| RNA, Small Interfering | 6 | 2018 | 2216 | 0.230 |
Why?
|
| Biotransformation | 6 | 2012 | 93 | 0.230 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 3639 | 0.230 |
Why?
|
| Sex Factors | 4 | 2023 | 2139 | 0.230 |
Why?
|
| Phosphorus Radioisotopes | 6 | 2015 | 44 | 0.230 |
Why?
|
| Ligands | 2 | 2023 | 995 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2015 | 4938 | 0.220 |
Why?
|
| Epoxide Hydrolases | 2 | 2008 | 53 | 0.210 |
Why?
|
| Mice, Inbred DBA | 2 | 2013 | 110 | 0.210 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 1217 | 0.210 |
Why?
|
| Computational Biology | 3 | 2019 | 1271 | 0.210 |
Why?
|
| Nitric Oxide | 1 | 2006 | 644 | 0.210 |
Why?
|
| Signal Transduction | 9 | 2020 | 11965 | 0.210 |
Why?
|
| Gonadal Hormones | 1 | 2021 | 4 | 0.200 |
Why?
|
| Sex Chromosomes | 1 | 2021 | 43 | 0.200 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2018 | 301 | 0.200 |
Why?
|
| Polycyclic Compounds | 2 | 2005 | 9 | 0.190 |
Why?
|
| Mice, Inbred ICR | 8 | 1997 | 239 | 0.190 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 2014 | 196 | 0.180 |
Why?
|
| Ampicillin | 1 | 2019 | 58 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8873 | 0.180 |
Why?
|
| Rats, Inbred F344 | 4 | 2014 | 224 | 0.170 |
Why?
|
| Petroleum | 1 | 2019 | 3 | 0.170 |
Why?
|
| Pregnenolone Carbonitrile | 3 | 1997 | 4 | 0.170 |
Why?
|
| Soil Pollutants | 1 | 2019 | 12 | 0.170 |
Why?
|
| Colitis | 1 | 2022 | 340 | 0.170 |
Why?
|
| Epithelial Cells | 4 | 2016 | 1818 | 0.170 |
Why?
|
| Multidrug Resistance-Associated Proteins | 2 | 2017 | 83 | 0.170 |
Why?
|
| Lipid Peroxides | 1 | 2018 | 22 | 0.170 |
Why?
|
| Inflammation | 7 | 2022 | 2522 | 0.170 |
Why?
|
| Autoradiography | 3 | 2015 | 132 | 0.170 |
Why?
|
| Kidney | 5 | 1997 | 2146 | 0.170 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2020 | 193 | 0.170 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 7548 | 0.160 |
Why?
|
| Gene Expression | 1 | 2007 | 3570 | 0.160 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 634 | 0.160 |
Why?
|
| Cell Survival | 5 | 2015 | 3045 | 0.160 |
Why?
|
| Aorta | 1 | 2002 | 692 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 363 | 0.150 |
Why?
|
| Oxidoreductases | 2 | 1995 | 171 | 0.150 |
Why?
|
| Microsomes | 3 | 2011 | 61 | 0.150 |
Why?
|
| Bufanolides | 1 | 2017 | 19 | 0.150 |
Why?
|
| Membrane Proteins | 3 | 2019 | 2819 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 14289 | 0.150 |
Why?
|
| Enzymes | 1 | 2017 | 64 | 0.150 |
Why?
|
| Hepatocytes | 2 | 2017 | 351 | 0.150 |
Why?
|
| Fetus | 3 | 2015 | 601 | 0.140 |
Why?
|
| Mice, Transgenic | 3 | 2011 | 4143 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2005 | 935 | 0.140 |
Why?
|
| Heme Oxygenase-1 | 1 | 2016 | 54 | 0.140 |
Why?
|
| Receptors, Steroid | 1 | 2018 | 286 | 0.140 |
Why?
|
| Metabolome | 1 | 2019 | 344 | 0.140 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 201 | 0.140 |
Why?
|
| Benzoflavones | 1 | 1995 | 1 | 0.140 |
Why?
|
| Teichoic Acids | 2 | 2012 | 13 | 0.140 |
Why?
|
| Estrogen Antagonists | 1 | 1997 | 184 | 0.140 |
Why?
|
| Time Factors | 5 | 2016 | 12926 | 0.140 |
Why?
|
| Cytokines | 5 | 2017 | 2809 | 0.140 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2012 | 93 | 0.140 |
Why?
|
| Mitochondria | 1 | 2023 | 1282 | 0.140 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2015 | 23 | 0.140 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 217 | 0.140 |
Why?
|
| Activation, Metabolic | 1 | 2015 | 3 | 0.130 |
Why?
|
| Pulmonary Edema | 2 | 2017 | 80 | 0.130 |
Why?
|
| Microvessels | 1 | 2016 | 135 | 0.130 |
Why?
|
| Diethylstilbestrol | 1 | 1995 | 109 | 0.130 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 3 | 2012 | 108 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 589 | 0.130 |
Why?
|
| Transcription Factor RelB | 1 | 2015 | 16 | 0.130 |
Why?
|
| Triazoles | 1 | 2000 | 617 | 0.130 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2015 | 94 | 0.130 |
Why?
|
| Malondialdehyde | 1 | 2015 | 47 | 0.130 |
Why?
|
| Limit of Detection | 1 | 2015 | 78 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 345 | 0.130 |
Why?
|
| Aldehydes | 1 | 2015 | 44 | 0.130 |
Why?
|
| F2-Isoprostanes | 1 | 2015 | 28 | 0.130 |
Why?
|
| Anti-Ulcer Agents | 1 | 2015 | 101 | 0.130 |
Why?
|
| Biomarkers | 4 | 2017 | 5047 | 0.130 |
Why?
|
| Capillaries | 1 | 2015 | 99 | 0.130 |
Why?
|
| Reactive Oxygen Species | 5 | 2023 | 987 | 0.120 |
Why?
|
| RNA Interference | 2 | 2016 | 1408 | 0.120 |
Why?
|
| Mice, Inbred Strains | 2 | 2014 | 521 | 0.120 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2014 | 31 | 0.120 |
Why?
|
| Pulmonary Circulation | 1 | 2015 | 131 | 0.120 |
Why?
|
| Camptothecin | 1 | 2017 | 517 | 0.120 |
Why?
|
| DNA, Complementary | 1 | 2016 | 869 | 0.120 |
Why?
|
| Adrenomedullin | 1 | 2015 | 104 | 0.120 |
Why?
|
| Caffeine | 1 | 2014 | 87 | 0.120 |
Why?
|
| Chemokine CCL2 | 2 | 2011 | 203 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2017 | 2450 | 0.120 |
Why?
|
| Leukocyte Count | 1 | 2015 | 684 | 0.120 |
Why?
|
| Biological Products | 1 | 2017 | 274 | 0.120 |
Why?
|
| Environmental Pollutants | 1 | 1994 | 83 | 0.110 |
Why?
|
| Benzene Derivatives | 2 | 2007 | 23 | 0.110 |
Why?
|
| Pyrenes | 2 | 2023 | 9 | 0.110 |
Why?
|
| Chlorpromazine | 1 | 2012 | 17 | 0.110 |
Why?
|
| Pharmacokinetics | 1 | 2012 | 42 | 0.110 |
Why?
|
| Immunologic Factors | 1 | 2017 | 649 | 0.110 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 448 | 0.110 |
Why?
|
| Databases, Genetic | 1 | 2016 | 745 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 5539 | 0.110 |
Why?
|
| Midazolam | 1 | 2012 | 75 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 568 | 0.110 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 852 | 0.110 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2011 | 10 | 0.100 |
Why?
|
| Anesthetics, Intravenous | 1 | 2012 | 73 | 0.100 |
Why?
|
| Antioxidants | 1 | 2015 | 507 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 677 | 0.100 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 174 | 0.100 |
Why?
|
| Soil | 2 | 2023 | 48 | 0.100 |
Why?
|
| Cell Cycle | 2 | 2014 | 2084 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 3154 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 2330 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2015 | 558 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 152 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 2012 | 1073 | 0.100 |
Why?
|
| Alleles | 1 | 2017 | 2437 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 907 | 0.100 |
Why?
|
| Isoenzymes | 2 | 2015 | 614 | 0.090 |
Why?
|
| Neutrophils | 1 | 2015 | 835 | 0.090 |
Why?
|
| Drug Interactions | 3 | 2017 | 553 | 0.090 |
Why?
|
| Inactivation, Metabolic | 3 | 2018 | 37 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2023 | 2947 | 0.090 |
Why?
|
| Proteomics | 1 | 2017 | 1380 | 0.090 |
Why?
|
| Drug Synergism | 3 | 2014 | 1313 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2016 | 1549 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 1498 | 0.080 |
Why?
|
| Cell Line, Tumor | 5 | 2018 | 14551 | 0.080 |
Why?
|
| Apoproteins | 1 | 2008 | 37 | 0.080 |
Why?
|
| Cell Line | 3 | 2015 | 5114 | 0.080 |
Why?
|
| Genotype | 1 | 2017 | 4109 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2011 | 448 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 191 | 0.080 |
Why?
|
| Mammary Glands, Animal | 1 | 2012 | 533 | 0.080 |
Why?
|
| Spices | 1 | 2007 | 5 | 0.080 |
Why?
|
| Texas | 1 | 2019 | 6311 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 461 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 3 | 2006 | 3203 | 0.080 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2008 | 103 | 0.080 |
Why?
|
| Cytochromes | 1 | 2007 | 10 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 2992 | 0.070 |
Why?
|
| Cytochrome P-450 CYP1A2 Inhibitors | 1 | 2006 | 2 | 0.070 |
Why?
|
| Quinone Reductases | 1 | 2006 | 6 | 0.070 |
Why?
|
| NADPH Dehydrogenase | 1 | 2006 | 10 | 0.070 |
Why?
|
| Lymphoid Tissue | 1 | 2006 | 95 | 0.070 |
Why?
|
| Risk Factors | 2 | 2021 | 17523 | 0.070 |
Why?
|
| Acute-Phase Proteins | 1 | 2005 | 79 | 0.070 |
Why?
|
| Models, Biological | 2 | 2007 | 3254 | 0.070 |
Why?
|
| Sulfates | 2 | 1995 | 45 | 0.070 |
Why?
|
| Apoptosis | 3 | 2015 | 7591 | 0.060 |
Why?
|
| Phenobarbital | 2 | 1997 | 48 | 0.060 |
Why?
|
| Oxazines | 2 | 2007 | 43 | 0.060 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2004 | 5 | 0.060 |
Why?
|
| Diet | 2 | 2011 | 1440 | 0.060 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 1450 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2007 | 584 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 6009 | 0.060 |
Why?
|
| Tight Junction Proteins | 1 | 2022 | 13 | 0.060 |
Why?
|
| Coumarins | 1 | 2022 | 33 | 0.060 |
Why?
|
| Dextran Sulfate | 1 | 2022 | 72 | 0.050 |
Why?
|
| Xenobiotics | 1 | 2022 | 44 | 0.050 |
Why?
|
| Benzopyrene Hydroxylase | 1 | 2002 | 4 | 0.050 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 1399 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2002 | 82 | 0.050 |
Why?
|
| Temperature | 1 | 2023 | 506 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 406 | 0.050 |
Why?
|
| Models, Animal | 1 | 2004 | 664 | 0.050 |
Why?
|
| Protective Factors | 1 | 2021 | 106 | 0.050 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 2 | 1998 | 14 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 943 | 0.050 |
Why?
|
| Response Elements | 1 | 2000 | 193 | 0.050 |
Why?
|
| Plasmids | 1 | 2002 | 837 | 0.040 |
Why?
|
| Biodegradation, Environmental | 1 | 2019 | 19 | 0.040 |
Why?
|
| Hydrocarbons | 1 | 2019 | 23 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 577 | 0.040 |
Why?
|
| Epigenomics | 1 | 2020 | 266 | 0.040 |
Why?
|
| Gestational Age | 1 | 2022 | 1069 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2019 | 134 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 1998 | 122 | 0.040 |
Why?
|
| Pleural Effusion | 1 | 2000 | 201 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2010 | 2027 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 950 | 0.040 |
Why?
|
| Adult | 3 | 2020 | 77950 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 490 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 170 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2000 | 842 | 0.040 |
Why?
|
| Carboxylesterase | 1 | 2017 | 33 | 0.040 |
Why?
|
| Ovary | 1 | 2021 | 668 | 0.040 |
Why?
|
| Mutagens | 1 | 1998 | 187 | 0.040 |
Why?
|
| Testis | 1 | 2021 | 717 | 0.040 |
Why?
|
| Butadienes | 1 | 1996 | 35 | 0.040 |
Why?
|
| Epoxy Compounds | 1 | 1996 | 55 | 0.040 |
Why?
|
| 7-Alkoxycoumarin O-Dealkylase | 2 | 1993 | 4 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2017 | 385 | 0.040 |
Why?
|
| Corn Oil | 1 | 1995 | 15 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme Inducers | 1 | 2015 | 3 | 0.030 |
Why?
|
| Acetaminophen | 1 | 1997 | 116 | 0.030 |
Why?
|
| Poly I-C | 1 | 2015 | 29 | 0.030 |
Why?
|
| Hydroxylation | 1 | 1995 | 65 | 0.030 |
Why?
|
| Alanine Transaminase | 2 | 2012 | 227 | 0.030 |
Why?
|
| Diquat | 1 | 1995 | 1 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2019 | 1764 | 0.030 |
Why?
|
| Thymidine | 2 | 1992 | 155 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 410 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 208 | 0.030 |
Why?
|
| Breast | 1 | 2002 | 1344 | 0.030 |
Why?
|
| Waste Products | 1 | 2014 | 3 | 0.030 |
Why?
|
| Brain | 1 | 2007 | 4113 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 4557 | 0.030 |
Why?
|
| Necrosis | 1 | 2015 | 580 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2014 | 515 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 671 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2014 | 249 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2012 | 185 | 0.030 |
Why?
|
| Survival Rate | 1 | 2006 | 12221 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1077 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 2012 | 231 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 931 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 891 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 1442 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2012 | 205 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2011 | 66 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 2074 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 244 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2012 | 886 | 0.020 |
Why?
|
| Reference Values | 1 | 1993 | 1099 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2012 | 235 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 3343 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1996 | 840 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2012 | 193 | 0.020 |
Why?
|
| Kinetics | 1 | 1993 | 2049 | 0.020 |
Why?
|
| Epithelium | 1 | 2012 | 720 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2012 | 410 | 0.020 |
Why?
|
| DNA Replication | 1 | 1992 | 744 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2054 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2012 | 421 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 6100 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 1466 | 0.020 |
Why?
|
| Isotope Labeling | 2 | 1998 | 142 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2006 | 682 | 0.020 |
Why?
|
| Animals, Outbred Strains | 1 | 2004 | 14 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2019 | 5270 | 0.020 |
Why?
|
| Neoplasms, Experimental | 2 | 2002 | 750 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 1054 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 875 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1037 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 3552 | 0.010 |
Why?
|
| Neoplasms | 2 | 2020 | 15193 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 4757 | 0.010 |
Why?
|
| Obesity | 1 | 2012 | 2884 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 1304 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 3033 | 0.010 |
Why?
|
| Milk, Human | 1 | 2002 | 277 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 2195 | 0.010 |
Why?
|
| Myeloproliferative Disorders | 1 | 2006 | 767 | 0.010 |
Why?
|
| Chrysenes | 1 | 1998 | 3 | 0.010 |
Why?
|
| Mutagenicity Tests | 1 | 1998 | 69 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 4233 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 6089 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 32848 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 1062 | 0.010 |
Why?
|
| Cattle | 1 | 1996 | 783 | 0.010 |
Why?
|
| Hydroquinones | 1 | 1994 | 28 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 5395 | 0.010 |
Why?
|
| Binding Sites | 1 | 1997 | 2171 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1993 | 110 | 0.010 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 1992 | 41 | 0.010 |
Why?
|
| Skin | 1 | 1998 | 1259 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1993 | 337 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 15179 | 0.000 |
Why?
|
| Adolescent | 1 | 2007 | 31252 | 0.000 |
Why?
|
| Child | 1 | 2007 | 29154 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 4367 | 0.000 |
Why?
|
| Aging | 1 | 1993 | 1582 | 0.000 |
Why?
|
| Aged | 1 | 2007 | 70117 | 0.000 |
Why?
|
| Middle Aged | 1 | 2007 | 86204 | 0.000 |
Why?
|